Dr. Robert J. Dobrzynski JR., M.D.
Endocrinology & Diabetes (Endocrinology, Diabetes & Metabolism Physician)
100 Highland Ave, 203
Providence, RI 02906
Who else practices at this address →
Providence County includes mental health (6% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Years since graduation
- 30
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 706
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Endocrinology, Diabetes & Metabolism Physician primary
RI license MD10593
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- The Miriam Hospital Providence, RI
- Southcoast Hospitals Group Fall River, MA
- Kent County Memorial Hospital Warwick, RI
- Women & Infants Hospital of Rhode Island Providence, RI
- South County Hospital Inc Wakefield, RI
Medical groups
- Diabetes and Endocrinology Associates, Inc. (5 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 706
- Services billed
- 10,382
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Blood test, thyroid stimulating hormone (tsh) | 1,162 | 648 |
| Insertion of needle into vein for collection of blood sample | 1,099 | 629 |
| Hemoglobin a1c level | 1,080 | 541 |
| Blood test, comprehensive group of blood chemicals | 930 | 454 |
| Established patient office or other outpatient visit, 30-39 minutes | 866 | 426 |
| Thyroxine (thyroid chemical), free | 806 | 489 |
| Thyroid hormone, t3 measurement, free | 587 | 341 |
| Established patient office or other outpatient visit, 20-29 minutes | 455 | 336 |
| Urine microalbumin (protein) level | 335 | 249 |
| Creatinine level to test for kidney function or muscle injury | 334 | 248 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Levothyroxine Sodium Other prescribers in Providence, RI | 2,376 |
| Ozempic (semaglutide) Other prescribers in Providence, RI | 1,203 |
| Glimepiride Other prescribers in Providence, RI | 1,122 |
| Metformin Hcl Other prescribers in Providence, RI | 938 |
| Jardiance (empagliflozin) Other prescribers in Providence, RI | 681 |
| Farxiga (dapagliflozin propanediol) Other prescribers in Providence, RI | 671 |
| Atorvastatin Calcium Other prescribers in Providence, RI | 658 |
| Synthroid (levothyroxine sodium) Other prescribers in Providence, RI | 516 |
| Nano 2nd Gen Pen Needle (pen needle, diabetic) Other prescribers in Providence, RI | 503 |
| Lantus Solostar (insulin glargine,hum.rec.anlog) Other prescribers in Providence, RI | 444 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 6 companies reported 48 payments worth $44,509 in total to this clinician.
| Novo Nordisk Inc | $30,143 |
|---|---|
| Dexcom, Inc. | $14,116 |
| AbbVie Inc. | $142 |
| Mannkind Corporation | $42.50 |
| Sequel Med Tech, LLC | $41.02 |
| Amgen Inc. | $24.70 |
| Compensation for services other than consulting (speaking, faculty) | $27,638 |
|---|---|
| Speaking at a medical education program | $12,639 |
| Travel and Lodging | $2,487 |
| Food and Beverage | $1,703 |
| Education | $42.50 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Dexcom, Inc. Feb 5, 2025 | Speaking at a medical education program DEXCOM G7 GSS (161); DEXCOM STELO GLUCOSE BIOSENSOR · Endocrinology | $6,128 |
| Novo Nordisk Inc Mar 8, 2025 | Compensation for services other than consulting (speaking, faculty) Ozempic · Diabetes | $6,103 |
| Novo Nordisk Inc Apr 10, 2025 | Compensation for services other than consulting (speaking, faculty) Ozempic · Diabetes | $3,604 |
| Novo Nordisk Inc Nov 12, 2025 | Compensation for services other than consulting (speaking, faculty) Ozempic · Diabetes | $3,604 |
| Novo Nordisk Inc Oct 15, 2025 | Compensation for services other than consulting (speaking, faculty) Ozempic · Diabetes | $3,604 |
| Novo Nordisk Inc May 28, 2025 | Compensation for services other than consulting (speaking, faculty) Ozempic · Diabetes | $3,023 |
| Novo Nordisk Inc Apr 3, 2025 | Compensation for services other than consulting (speaking, faculty) Ozempic · Diabetes | $3,023 |
| Dexcom, Inc. Jun 12, 2025 | Speaking at a medical education program DEXCOM G7 GSS (161); DEXCOM STELO GLUCOSE BIOSENSOR · Endocrinology | $2,298 |
| Dexcom, Inc. May 5, 2025 | Speaking at a medical education program DEXCOM G7 GSS (161); DEXCOM STELO GLUCOSE BIOSENSOR · Endocrinology | $2,298 |
| Novo Nordisk Inc Oct 16, 2025 | Compensation for services other than consulting (speaking, faculty) Ozempic · Diabetes | $2,093 |
All 26 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Novo Nordisk Inc Nov 12, 2025 | Compensation for services other than consulting (speaking, faculty) Ozempic · Diabetes | $3,604 |
| Novo Nordisk Inc Nov 12, 2025 | Travel and Lodging Ozempic · Diabetes · travel to West Hartford, CT · in-kind | $119 |
| Novo Nordisk Inc Oct 16, 2025 | Compensation for services other than consulting (speaking, faculty) Ozempic · Diabetes | $2,093 |
| Novo Nordisk Inc Oct 15, 2025 | Compensation for services other than consulting (speaking, faculty) Ozempic · Diabetes | $3,604 |
| Novo Nordisk Inc Oct 15, 2025 | Travel and Lodging Ozempic · Diabetes · travel to Mystic, CT · in-kind | $61.60 |
| Novo Nordisk Inc Oct 7, 2025 | Compensation for services other than consulting (speaking, faculty) Ozempic · Diabetes | $494 |
| Dexcom, Inc. Sep 9, 2025 | Speaking at a medical education program DEXCOM G7 GSS (161); DEXCOM STELO GLUCOSE BIOSENSOR · Endocrinology | $1,915 |
| Mannkind Corporation Aug 22, 2025 | Education AFREZZA · DIABETES MEDICINE · in-kind | $42.50 |
| Dexcom, Inc. Jun 12, 2025 | Speaking at a medical education program DEXCOM G7 GSS (161); DEXCOM STELO GLUCOSE BIOSENSOR · Endocrinology | $2,298 |
| Dexcom, Inc. Jun 12, 2025 | Travel and Lodging DEXCOM G7 GSS (161); DEXCOM STELO GLUCOSE BIOSENSOR · Endocrinology · travel to North Falmouth, MA | $109 |
| Novo Nordisk Inc May 28, 2025 | Compensation for services other than consulting (speaking, faculty) Ozempic · Diabetes | $3,023 |
| Dexcom, Inc. May 7, 2025 | Travel and Lodging DEXCOM G7 GSS (161); DEXCOM STELO GLUCOSE BIOSENSOR · Endocrinology · travel to North Falmouth, MA | $119 |
| Dexcom, Inc. May 5, 2025 | Speaking at a medical education program DEXCOM G7 GSS (161); DEXCOM STELO GLUCOSE BIOSENSOR · Endocrinology | $2,298 |
| Novo Nordisk Inc Apr 24, 2025 | Compensation for services other than consulting (speaking, faculty) | $2,093 |
| Novo Nordisk Inc Apr 10, 2025 | Compensation for services other than consulting (speaking, faculty) Ozempic · Diabetes | $3,604 |
| Novo Nordisk Inc Apr 10, 2025 | Travel and Lodging Ozempic · Diabetes · travel to Thompson, CT · in-kind | $57.40 |
| Novo Nordisk Inc Apr 3, 2025 | Compensation for services other than consulting (speaking, faculty) Ozempic · Diabetes | $3,023 |
| Novo Nordisk Inc Mar 8, 2025 | Compensation for services other than consulting (speaking, faculty) Ozempic · Diabetes | $6,103 |
| Novo Nordisk Inc Mar 8, 2025 | Travel and Lodging Ozempic · Diabetes · travel to Orlando, FL · in-kind | $477 |
| Novo Nordisk Inc Mar 8, 2025 | Travel and Lodging Ozempic · Diabetes · travel to Orlando, FL · in-kind | $399 |
| Novo Nordisk Inc Mar 8, 2025 | Travel and Lodging Ozempic · Diabetes · travel to Orlando, FL · in-kind | $189 |
| Dexcom, Inc. Mar 7, 2025 | Travel and Lodging DEXCOM G7 GSS (161); DEXCOM STELO GLUCOSE BIOSENSOR · Endocrinology · travel to Austin, TX · in-kind | $612 |
| Dexcom, Inc. Feb 5, 2025 | Speaking at a medical education program DEXCOM G7 GSS (161); DEXCOM STELO GLUCOSE BIOSENSOR · Endocrinology | $6,128 |
| Dexcom, Inc. Jan 30, 2025 | Travel and Lodging DEXCOM G7 GSS (161); DEXCOM STELO GLUCOSE BIOSENSOR · Endocrinology · travel to Austin, TX | $103 |
| Dexcom, Inc. Jan 30, 2025 | Travel and Lodging DEXCOM G7 GSS (161); DEXCOM STELO GLUCOSE BIOSENSOR · Endocrinology · travel to Austin, TX | $89.60 |
| Dexcom, Inc. Jan 28, 2025 | Travel and Lodging DEXCOM G7 GSS (161); DEXCOM STELO GLUCOSE BIOSENSOR · Endocrinology · travel to Austin, TX · in-kind | $150 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.